Choosing between frequentist and bayesian frameworks and the corresponding statistical package

Network Meta-Analysis: Evidence Synthesis with Mixed Treatment Comparison

Volumn , Issue , 2014, Pages 103-115

  Biondi Zoccai, Giuseppe ^a   D'Ascenzo, Fabrizio ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

Author keywords

Adjusted indirect comparison; Bayesian inference; Bayesian statistics; frequentist inference; frequentist statistics; mixed treatment comparison; network meta analysis; statistical package; statistical software

Indexed keywords

EID: 84919891362     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (67)

1. Guyatt GH, Rennie D, editors. Users' Guides to the Medical Literature: A Manual of Evidence-Based Clinical Practice. Chicago: AMA Press; 2002.
2. Biondi-Zoccai G, Landoni G, Modena MG. A journey into clinical evidence: from case reports to mixed treatment comparisons. HSR Proc Intensive Care Cardiovasc Anesth 2011; 3: 93-6.
3. Greco T, Zangrillo A, Biondi-Zoccai G, Landoni G. Meta-analysis: pitfalls and hints. Heart Lung Vessel 2013; 5: 219-225.
4. Spiegelhalter DJ, Freedman LS, Parmar MK. Applying Bayesian ideas in drug development and clinical trials. Stat Med 1993; 12: 1501-11.
5. Guyatt GH, Mills EJ, Elbourne D. In the Era of Systematic Reviews, Does the Size of an Individual Trial Still Matter? PLoS Med 2008; 5: e4.
6. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol 1997; 50: 683-91.
7. Song F, Altman DG, Glenny AM, Deeks JJ. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ 2003; 326: 472.
8. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med 2002; 21: 2313-24.
9. Chootrakool H, Shi JQ. Meta-analysis of multi-arm trials using empirical logistic transform. The Open Medical Informatics Journal 2008; 2: 112-16.
10. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004; 23: 3105-24.
11. Biondi-Zoccai G, Lotrionte M, Landoni G, Modena MG. The rough guide to systematic reviews and meta-analyses. HSR Proc Intensive Care Cardiovasc Anesth 2011; 3: 161-73.
12. Song F, Harvey I, Lilford R. Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions. J Clin Epidemiol 2008; 61: 455-63.
13. Jones B, Roger J, Lane PW, Lawton A, Fletcher C, Cappelleri JC, Tate H, Moneuse P; PSI Health Technology Special Interest Group, Evidence Synthesis sub-team. Statistical approaches for conducting network meta-analysis in drug development. Pharm Stat 2011; 10: 523-31.
14. Song F, Clark A, Bachmann MO, Maas J. Simulation evaluation of statistical properties of methods for indirect and mixed treatment comparisons. BMC Med Res Methodol 2012; 12: 138.
15. Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003; 289: 2534-44.
16. Altman D, Machin D, Bryant T, Gardner S. Statistics with Confidence. 2nd edition. London: Wiley-Blackwell; 2000.
17. Jansen JP, Fleurence R, Devine B, Itzler R, Barrett A, Hawkins N, Lee K, Boersma C, Annemans L, Cappelleri JC. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value Health 2011;14:417-28.
18. Goodman SN. Towards evidence based medical statistics: 1. The P value fallacy. Ann Intern Med 1999; 120: 995-1004.
19. Spiegelhalter DJ, Myles JP, Jones DR, Abrams KR. Methods in health service research. An introduction to bayesian methods in health technology assessment. BMJ 1999; 319: 508-12.
20. Spiegelhalter DJ, Myles JP, Jones DR, Abrams KR. Bayesian methods in health technology assessment: a review. Health Technol Assess 2000; 4: 1-130.
21. Ades AE. A chain of evidence with mixed comparisons: models for multi-parameter synthesis and consistency of evidence. Stat Med 2003; 22: 2995-3016.
22. Eddy DM, Hasselblad V, Shachter R. Meta-analysis by the confidence profile method: the statistical synthesis of evidence. Boston: Academic Press; 1992.
23. Coleman CI, Phung OJ, Cappelleri JC, Baker WL, Kluger J, White CM, Sobieraj DM. Use of Mixed Treatment Comparisons in Systematic Reviews. Rockville: Agency for Healthcare Research and Quality; 2012.
24. Ades AE, Welton NJ, Caldwell D, Price M, Goubar A, Lu G. Multiparameter evidence synthesis in epidemiology and medical decision-making. J Health Serv Res Policy 2008; 13 Suppl 3: 12-22.
25. Dias S, Welton NJ, Sutton AJ, Ades AE. Evidence synthesis for decision making 1: introduction. Med Decis Making 2013; 33: 597-606.
26. Dias S, Sutton AJ, Ades AE, Welton NJ. Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials. Med Decis Making 2013; 33: 607-17.
27. Dias S, Sutton AJ, Welton NJ, Ades AE. Evidence synthesis for decision making 3: heterogeneity--subgroups, meta-regression, bias, and bias-adjustment. Med Decis Making 2013; 33: 618-40.
28. Dias S, Welton NJ, Sutton AJ, Caldwell DM, Lu G, Ades AE. Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials. Med Decis Making 2013; 33: 641-56.
29. Dias S, Welton NJ, Sutton AJ, Ades AE. Evidence synthesis for decision making 5: the baseline natural history model. Med Decis Making 2013; 33: 657-70.
30. Dias S, Sutton AJ, Welton NJ, Ades AE. Evidence synthesis for decision making 6: embedding evidence synthesis in probabilistic cost-effectiveness analysis. Med Decis Making 2013; 33: 671-8.
31. Ades AE, Caldwell DM, Reken S, Welton NJ, Sutton AJ, Dias S. Evidence synthesis for decision making 7: a reviewer's checklist. Med Decis Making 2013; 33: 679-91.
32. Higgins JP, Whitehead A. Borrowing strength from external trials in a meta-analysis. Stat Med 1996; 15: 2733-49.
33. Lambert PC, Sutton AJ, Burton PR, Abrams KR, Jones DR. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS. Stat Med 2005; 24: 2401-28.
34. Higgins JP, Spiegelhalter DJ. Being sceptical about meta-analyses: a Bayesian perspective on magnesium trials in myocardial infarction. Int J Epidemiol 2002; 31: 96-104.
35. Youn JH, Lord J, Hemming K, Girling A, Buxton M. Bayesian meta-analysis on medical devices: application to implantable cardioverter defibrillators. Int J Technol Assess Health Care 2012; 28: 115-24
36. Ioannidis JPA. Why Most Published Research Findings Are False. PLoS Med 2005; 2: e124.
37. Warn DE, Thompson SG, Spiegelhalter DJ. Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. Stat Med 2002; 21: 1601-23.
38. Thompson SG, Smith TC, Sharp SJ. Investigating underlying risk as a source of heterogeneity in meta-analysis. Stat Med 1997; 16: 2741-58.
39. Sharp SJ, Thompson SG. Analysing the relationship between treatment effect and underlying risk in meta-analysis: comparison and development of approaches. Stat Med 2000; 19: 3251-74.
40. Achana FA, Cooper NJ, Dias S, Lu G, Rice SJ, Kendrick D, Sutton AJ. Extending methods for investigating the relationship between treatment effect and baseline risk from pairwise meta-analysis to network meta-analysis. Stat Med 2013; 32: 752-71.
41. Baker R, Jackson D. A new approach to outliers in meta-analysis. Health Care Manag Sci 2008; 11: 121-31.
42. Carlin BP, Hong H, Shamliyan TA, Sainfort F, Kane RL. Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons. Rockville: Agency for Healthcare Research and Quality; 2013.
43. Jonas DE, Wilkins TM, Bangdiwala S, Bann CM, Morgan LC, Thaler KJ, Amick HR, Gartlehner G. Findings of Bayesian Mixed Treatment Comparison Meta-Analyses: Comparison and Exploration Using Real-World Trial Data and Simulation. Rockville: Agency for Healthcare Research and Quality; 2013.
44. Gajic-Veljanoski O, Cheung AM, Bayoumi AM, Tomlinson G. The choice of a noninformative prior on between-study variance strongly affects predictions of future treatment effect. Med Decis Making 2013; 33: 356-68.
45. Cooper NJ, Spiegelhalter D, Bujkiewicz S, Dequen P, Sutton AJ. Use of implicit and explicit bayesian methods in health technology assessment. Int J Technol Assess Health Care 2013; 29: 336-42.
46. A Network Meta-Analysis Toolkit. Computing Multiple Interventions Methods Group. A Methods Group of the Cochrane Collaboration. Available from: http:// cmimg.cochrane.org/network-meta-analysis-toolkit (last accessed on March 31, 2014).
47. Mixed treatment comparison software. University of Ioannina, Ioannina, Greece. Available from: http://www.dhe.med.uoi.gr/software.htm (last accessed on March 31, 2014).
48. Programs & Code for Mixed Treatment Comparisons. University of Bristol, Bristol, UK. Available from: http://www.bristol.ac.uk/social-community-medicine/ projects/ mpes/code/ (last accessed on March 31, 2014).
49. Bayesian Analysis Using Gibbs Sampling (BUGS). Available from: http://www.mrc-bsu.cam.ac.uk/software/bugs/ (last accessed on March 31, 2014).
50. Fryback DG, Stout NK, Rosenberg MA. An elementary introduction to Bayesian computing using WinBUGS. Int J Technol Assess Health Care 2001; 17: 98-113.
51. Spiegelhalter DJ, Best NG, Carlin BP, Van Der Linde A. Bayesian measures of model complexity and fit. J R Stat Soc B 2002; 64: 583-639.
52. Lunn D, Spiegelhalter D, Thomas A, Best N. The BUGS project: Evolution, critique and future directions. Stat Med 2009; 28: 3049-67.
53. Greco T, Landoni G, Biondi-Zoccai G, D'Ascenzo F, Zangrillo A. A Bayesian network meta-analysis for binary outcome: how to do it. Stat Methods Med Res 2013 Oct 28 [Epub ahead of print] doi: 10.1177/0962280213500185.
54. MATBUGS. Available from: http://code.google.com/p/matbugs/ (last accessed on March 31, 2014).
55. R2WinBUGS. Available from: http://cran.r-project.org/web/packages/ R2WinBUGS/ index.html (last accessed on March 31, 2014).
56. Running WinBUGS through SAS. Available from: http://www2.mrc-bsu.cam.ac.uk/ bugs/winbugs/remoteSAS.html (last accessed on March 31, 2014).
57. WinBUGS & Stata. Available from: http://www.personal.leeds.ac.uk/~hssdg/ Stata/index.htm (last accessed on March 31, 2014).
58. Tan SH, Cooper NJ, Bujkiewicz S, Welton NJ, Caldwell DM, Sutton AJ. Novel presentational approaches were developed for reporting network meta-analysis. J Clin Epidemiol 2014 Feb 19 [Epub ahead of print] doi: 10.1016/j.jclinepi.2013.11.006.
59. Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol 2011; 64: 163-71.
60. van Valkenhoef G, Tervonen T, Zwinkels T, de Brock B, Hillege H. ADDIS: a decision support system for evidence-based medicine. Decision Support Systems 2013; 55: 459-75.
61. GeMTC. Available from: http://drugis.org/gemtc (last accessed on March 31, 2014).
62. Open Meta-Analyst. Available from: http://www.cebm.brown.edu/open_meta (last accessed on March 31, 2014).
63. Wells GA, Sultan SA, Chen L, Khan M, Coyle D. Indirect evidence: indirect treatment comparisons in meta-analysis. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2009.
64. Indirect Meta-analysis Tool. METCARDIO. Available from: http://www.metcardio. org/macros/IMT.xls (last accessed on March 31, 2014).
65. O'Regan C, Ghement I, Eyawo O, Guyatt GH, Mills EJ. Incorporating multiple interventions in meta-analysis: an evaluation of the mixed treatment comparison with the adjusted indirect comparison. Trials 2009; 10: 86.
66. Graham PL, Moran JL. Robust meta-analytic conclusions mandate the provision of prediction intervals in meta-analysis summaries. J Clin Epidemiol 2012; 65: 503-10.
67. D'Ascenzo F, Biondi-Zoccai G. Network meta-analyses: the "white whale" for cardiovascular specialists. J Cardiothorac Vasc Anesth 2014; 28: 169-73.